Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Sell

Relative Strength Index

Neutral

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Applied Therapeutics, Inc. Common Stock (APLT)

Pharmaceutical Preparations

https://www.appliedtherapeutics.com

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need.

545 5TH AVENUE, SUITE 1400
NEW YORK, NY

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/13/2019

Market Cap

679,314,090

Shares Outstanding

77,230,000

Weighted SO

77,229,207

Total Employees

N/A

Upcoming Earnings

08/08/2024

Beta

1.9920

Last Div

0.0000

Range

1.22-9.39

Chg

-0.0050

Avg Vol

1183020

Mkt Cap

679314090

Exch

NASDAQ

Country

US

Phone

212 220 9226

DCF Diff

4.7368

DCF

1.1772

Div Yield

0.0000

P/S

-2039.9823

EV Multiple

-9.1447

P/FV

11.7606

Div Yield %

0.0000

P/E

-5.2851

PEG

-0.1543

Payout

0.0000

Current Ratio

2.3046

Quick Ratio

2.3046

Cash Ratio

2.2075

DSO

-287.1772

DIO

0.0000

Op Cycle

-287.1772

DPO

1387.1034

CCC

-1674.2806

Gross Margin

3.1201

Op Margin

234.3423

Pretax Margin

483.7508

Net Margin

483.7508

Eff Tax Rate

0.0732

ROA

-1.2607

ROE

-5.7792

ROCE

-1.0775

NI/EBT

1.0000

EBT/EBIT

2.0643

EBIT/Rev

234.3423

Debt Ratio

0.0017

D/E

0.0030

LT Debt/Cap

0.0004

Total Debt/Cap

0.0030

Int Coverage

-108.2330

CF/Debt

-340.6372

Equity Multi

1.7651

Rec Turnover

-1.2710

Pay Turnover

0.2631

Inv Turnover

0.0000

FA Turnover

-1.6165

Asset Turnover

-0.0026

OCF/Share

-0.5088

FCF/Share

-0.5088

Cash/Share

0.8490

OCF/Sales

219.9309

FCF/OCF

1.0000

CF Coverage

-340.6372

ST Coverage

-395.8757

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

11.7606

P/B

11.7606

P/S

-2039.9823

P/E

-5.2851

P/FCF

-9.2756

P/OCF

-11.6249

P/CF

-11.6249

PEG

-0.1543

P/S

-2039.9823

EV Multiple

-9.1447

P/FV

11.7606

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. May 09, 21:00 Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting GlobeNewswire Inc. Apr 14, 21:50 Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results GlobeNewswire Inc. Feb 15, 04:18 APLT ????????????????? ROSEN ?? Applied Therapeutics, Inc. ????? APLT ??????????????? 2 ? 18 ?????? GlobeNewswire Inc. Feb 08, 21:02 APLT DEADLINE NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Applied Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT GlobeNewswire Inc. Feb 08, 16:34 APLT Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Applied Therapeutics, Inc. (APLT) GlobeNewswire Inc. Feb 03, 02:56 ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT GlobeNewswire Inc. Feb 03, 00:38 Kessler Topaz Meltzer & Check, LLP - APLT Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Applied Therapeutics, Inc. (APLT) GlobeNewswire Inc. Feb 01, 01:40 APLT INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit GlobeNewswire Inc. Jan 31, 00:19 ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT GlobeNewswire Inc. Jan 30, 02:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Capri, Applied Therapeutics, Nextracker, and Transocean and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jan 23, 02:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Kaspi, Applied Therapeutics, Cassava, and MGPI and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jan 22, 02:08 ROSEN, NATIONAL TRIAL LAWYERS, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT GlobeNewswire Inc. Jan 22, 01:30 APLT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit GlobeNewswire Inc. Jan 19, 15:18 APLT FRAUD NEWS: A Class Action has been Filed Against Applied Therapeutics, Inc. for Securities Fraud – Contact BFA Law by February 18 Court Deadline (NASDAQ:APLT) GlobeNewswire Inc. Jan 19, 02:15 ROSEN, A HIGHLY RECOGNIZED FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT GlobeNewswire Inc. Jan 12, 21:00 APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire Inc. Jan 10, 03:12 ROSEN, SKILLED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT GlobeNewswire Inc. Jan 07, 00:08 APLT Investor Alert: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against Applied Therapeutics, Inc. GlobeNewswire Inc. Jan 04, 01:53 ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT GlobeNewswire Inc. Jan 01, 15:11 APLT STOCK UPDATE: Applied Therapeutics, Inc. Investors are Notified of Upcoming Class Action Deadline; Contact BFA Law by February 18 (NASDAQ:APLT)

Revenue Product Segmentation